RNA Actuators are a
new category of synthetic gene regulators
Our RAP Platform™
Identify RNA Hotspots
Program for Druggability
Cell and Tissue Specific
Hundreds of Diseases
We are building a deep pipeline of therapeutic candidates that have the potential to transform the treatment of a wide variety of diseases.
Partnering to Capitalize on the Potential
Our platform enables expansive opportunities across multiple therapeutic areas. Given the enormity of the potential, we can’t do it all alone. We intend for our approach and unparalleled understanding of regRNAs, oligonucleotide technology and gene expression to open up vast horizons for drug discovery and development.
Partnering with biopharma companies with expertise in a given therapeutic area is integral to maximizing the potential of our platform for patients. Our aim is to empower partners with a rapid, efficient approach to targeting the diseases that matter most to them.